Research Publications

Papers | Other Publications | Books


Peer Reviewed Publications:

1. Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane.
Muqit MM, Stanga PE.
BR J Ophthalmol, 2004 Jul: 98(7):994-7. doi: 10.1136/bjophthalmol-2013-304452.
Epub 2014 Mar 21. PubMed PMID: 24659354.

2. The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients.
Vaidya A, Borgonovi E, Taylor RS, Sahel JA, Rizzo S, Stanga PE, Kukreja A, Walter P.
BMC Ophthalmol. 2014 April 14;14:49. doi:10.1186/1471-2415-14-49.
PubMed PMID: 24731533; PubMed Central PMCID: PM 3990272.

3. BRC Support. Swept-source optical coherence tomography imaging in conservative and surgical management of premacular haemorrhages showing inflammatory response.
Tanawade RG, Muqit MM, McLeod D, Stanga PE.
Clin Experiment Ophthalmol. 2015 Jan:43(1):77-79. doi:10.1111/ceo.12368.
Epub 2014 Aug13. PubMed PMID: 24902611.

4. BRC Support. In vivo imaging of cortical vitreous using 1050-nm swept-source deep range imaging optical coherence tomography.
Stanga PE, Sala-Puigdollers A, Caputo S, Jaberansari H, Cien M, Gray J, D’Souza Y, Charles SJ, Biswas S, Henson DB, McLeod D.
Am J Ophthalmol. 2014 Feb;157(2):397-404.e2. doi: 10.1016/j.ajo.2013.10.008.
Epub 2013 Oct 22.

5. BRC Support. Fourier-domain optical coherence tomography evaluation of retinal and optic nerve head neovascularisation in proliferative diabetic retinopathy.
Muqit MM, Stanga PE.
Br J Ophthalmol. 2014 Jan;98(1):65-72. doi: 10.1136/bjophthalmol-2013-303941.
Epub 2013 Oct 24.

6. BRC Support. Spatial changes of central field loss in diabetic retinopathy after laser.
Wang Y, Muqit MM, Stanga PE, Young LB, Henson DB.
Optom Vis Sci. 2014 Jan;91(1):111-20. doi: 10.1097/OPX.0000000000000103.

7. BRC Support. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE.
Acta Ophthalmol. 2013 May;91(3):251-8. doi: 10.1111/j.1755-3768.2011.02307.x.
Epub 2011 Dec 16.

8. BRC Support. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss.
da Cruz L, Coley BF, Dorn J, Merlini F, Filley E, Christopher P, Chen FK,Wuyyuru V, Sahel J,Stanga P, Humayun M, Greenberg RJ, Dagnelie G; Argus II Study Group.
Br J Ophthalmol. 2013 May;97(5):632-6. doi: 10.1136/bjophthalmol-2012-301525.
Epub 2013 Feb 20.

9. BRC Support. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study.
Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, Turner GS, Stanga PE.
Br J Ophthalmol. 2013 Feb;97(2):220-7. doi: 10.1136/bjophthalmol-2012-302189.
Epub 2012 Nov 24.

10. BRC Support. The Royal College of Ophthalmologists’ clinical guidelines for diabetic retinopathy: a summary.
Ghanchi F;
Diabetic Retinopathy Guidelines Working Group. Eye (Lond). 2013 Feb;27(2):285-7. doi: 10.1038/eye.2012.287.
Epub 2013 Jan 11. No abstract available.

11. BRC Support. Intravitreal injections: a healthcare failure modes and effects analysis.
Lanzetta P, Holz F, Monés J, Querques G, Stanga P, Veritti D, Barbone F, Brusaferro S, Isola M.
Ophthalmologica. 2013;230(3):151-64. doi: 10.1159/000354549.
Epub 2013 Aug 31.

12. BRC Support. Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements.
Barry MP, Dagnelie G; Argus II Study Group.
Invest Ophthalmol Vis Sci. 2012 Aug 1;53(9):5095-101. doi: 10.1167/iovs.12-9536.

13. BRC Support. Microstructural changes following Inadvertent multi-spot laser photocoagulation of the fovea.
Stanga PE, Muqit MM, Marcellino GR.
Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):945-7. doi: 10.1007/s00417-011-1719-4.
Epub 2011 Jun 10. No abstract available.

14. BRC Support. Interim results from the international trial of Second Sight’s visual prosthesis.
Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Sahel JA, Stanga PE, Cideciyan AV, Duncan JL, Eliott D, Filley E, Ho AC, Santos A, Safran AB, Arditi A, Del Priore LV, Greenberg RJ; Argus II Study Group.
Ophthalmology. 2012 Apr;119(4):779-88. doi: 10.1016/j.ophtha.2011.09.028.
Epub 2012 Jan 11.

15. BRC Support. Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders.
Muqit MM, Sanghvi C, McLauchlan R, Delgado C, Young LB, Charles SJ, Marcellino GR, Stanga PE.
Acta Ophthalmol. 2012 Mar;90(2):155-61. doi: 10.1111/j.1755-3768.2009.01854.x.
Epub 2010 Feb 16.

16. BRC Support. Presumed entecavir-induced ocular toxicity.
Muqit MK, Stanga PE, Vilar FJ, Patton N.
Eye (Lond). 2011 Dec;25(12):1665-8. doi: 10.1038/eye.2011.259. Epub 2011 Oct 21.
No abstract available.

17. BRC Support. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.
Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE.
Eye (Lond). 2011 Nov;25(11):1447-56. doi: 10.1038/eye.2011.188.
Epub 2011 Aug 5.

18. BRC Support. Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3.
Muqit MM, Marcellino GR, Henson DB, Fenerty CH, Stanga PE.
Retina. 2011 Sep;31(8):1699-707. doi: 10.1097/IAE.0b013e318207d188.

19. BRC Support. Argus II Study Group. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task.
Ahuja AK, Dorn JD, Caspi A, McMahon MJ, Dagnelie G, Dacruz L, Stanga P, Humayun MS, Greenberg RJ;
Br J Ophthalmol. 2011 Apr;95(4):539-43. doi: 10.1136/bjo.2010.179622.
Epub 2010 Sep 29.

20. BRC Support. Spatial and spectral imaging of retinal laser photocoagulation burns.
Muqit MM, Denniss J, Nourrit V, Marcellino GR, Henson DB, Schiessl I, Stanga PE.
Invest Ophthalmol Vis Sci. 2011 Feb 23;52(2):994-1002. doi: 10.1167/iovs.10-6309.

21. BRC Support. High-resolution hyperspectral imaging of the retina with a modified fundus camera.
Nourrit V, Denniss J, Muqit MM, Schiessl I, Fenerty C, Stanga PE, Henson DB.
J Fr Ophtalmol. 2010 Dec;33(10):686-92. doi: 10.1016/j.jfo.2010.10.010.
Epub 2010 Nov 19.

22. BRC Support. Fourier-Domain Optical Coherence Tomography Imaging of Gas Tamponade Following Macular Hole Surgery.
MMK Muqit, I Akram, GS Turner, PE Stanga.
Ophthalmic Surg Lasers Imaging. 2010 Dec 1;41 Online:e1-6. doi: 10.3928/15428877-20101124-16.

23. BRC Support. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser.
PE Stanga, MMK Muqit.
Retina. 2010 Nov-Dec;30(10):1749-50; author reply 1750-1.

24. BRC Support. Laser Tissue Interactions.
MMK. Muqit, GR Marcellino, DB. Henson, LB Young, N Patton, SJ Charles, GS Turner, PE Stanga.
Ophthalmology. 2010 Oct;117(10):2039, 2039.e1.

25. BRC Support. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task.
Ahuja AK, Dorn JD, Caspi A, McMahon MJ, Dagnelie G, Dacruz L, Stanga P, Humayun MS, Greenberg RJ; Argus II Study Group.
Br J Ophthalmol. 2010 Sep 29. [Epub ahead of print]

26. BRC Support. Spatial and Spectral Imaging of Retinal Laser Photocoagulation Burns.
MMK Muqit, J Denniss, V Nouritt, DB Henson, I Schiessel, PE Stanga.
Invest Ophthalmol Vis Sci. 2010 Sep 22. [Epub ahead of print]

27. BRC Support. Nidek MP-1 microperimetry and Fourier domain optical coherence tomography (FD-OCT) in X linked retinoschisis.
Biswas S, Funnell CL, Gray J, Bunting R, Lloyd IC, Stanga PE.
Br J Ophthalmol. 2010 Jul;94(7):949-50.